Inflammatory markers and the risk of Alzheimer disease: The Framingham Study

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Cerebral amyloid angiopathy. A critical review.

Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070

Inflammatory mediators in the elderly

Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928

Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study

Rost, N. S., Wolf, P. A., Kase, C. S., Kelly‐Hayes, M., Silbershatz, H., Massaro, J. M., D’Agostino, R. B., Franzblau, C., & Wilson, P. W. F. (2001) · Stroke · doi:10.1161/hs1101.098151 · Cited by 806

Passage of cytokines across the blood–brain barrier

Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

Vasan, R. S., SULLIVAN, L. M., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Sawyer, D. B., Levy, D. A., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 763

β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721

Inflammatory markers and cognition in well-functioning African-American and white elders

Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706

Immune modulation of learning, memory, neural plasticity and neurogenesis

Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention

Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261

Systemic inflammation and disease progression in Alzheimer disease

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139

Proinflammatory Cytokines, Aging, and Age-Related Diseases

Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094

Neuroinflammation: The role and consequences

Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P., & Ma, D. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.10.004 · Cited by 776

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702

Treating inflammation by blocking interleukin-1 in humans

Dinarello, C. A., & van der Meer, J. W. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.008 · Cited by 560

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447

Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

Puzianowska-Kuźnicka, M., Owczarz, M., Wieczorowska-Tobis, K., Nadrowski, P., Chudek, J., Slusarczyk, P., Skalska, A., Jonas, M., Franek, E., & Mossakowska, M. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0076-x · Cited by 445

Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427

Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging

Lieb, W. (2009) · JAMA · doi:10.1001/jama.2009.1836 · Cited by 428

Microglia Priming with Aging and Stress

Niraula, A., Sheridan, J. F., & Godbout, J. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.185 · Cited by 398

Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial

Kiecolt‐Glaser, J. K., Bennett, J. M., Andridge, R., Peng, J., Shapiro, C. L., Malarkey, W. B., Emery, C. F., Layman, R. M., Mrózek, E., & Glaser, R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.8860 · Cited by 409

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease

Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387

Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review

Zhan, X., Stamova, B. S., & Sharp, F. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00042 · Cited by 361

Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling

Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00170 · Cited by 330

Innovative diagnostic tools for early detection of Alzheimer's disease

Laske, C., Sohrabi, H. R., Frost, S. M., López-de-Ipiña, K., Garrard, P., Buscema, M., Dauwels, J., Soekadar, S. R., Mueller, S., Linnemann, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.004 · Cited by 316

The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis

Koyama, A. K., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. S. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls187 · Cited by 332

Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease

Lee, J. K., & Kim, N. (2017) · Molecules · doi:10.3390/molecules22081287 · Cited by 326

70-year legacy of the Framingham Heart Study

Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305

Anakinra Therapy for Non-cancer Inflammatory Diseases

Cavalli, G., & Dinarello, C. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01157 · Cited by 307

Adipokines: a link between obesity and dementia?

Kiliaan, A. J., Arnoldussen, I. A. C., & Gustafson, D. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70085-7 · Cited by 290

Human gut microbiota: the links with dementia development

Alkasir, R., Li, J., Li, X., Jin, M., & Zhu, B. (2016) · Protein & Cell · doi:10.1007/s13238-016-0338-6 · Cited by 289

A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1Β, TNF-α and IL-6 Challenges in C57BL/6 Mice

Skelly, D., Hennessy, E., Dansereau, M., & Cunningham, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069123 · Cited by 289

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

McAlpine, F. E., Lee, J., Harms, A. S., Ruhn, K. A., Blurton-Jones, M. M., Hong, J. J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 274

The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β

Wu, X., Lu, Y., Dong, Y., Zhang, G., Zhang, Y., Xu, Z., Culley, D. J., Crosby, G. J., Marcantonio, E. R., Tanzi, R. E., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.002 · Cited by 265

Immune aging, dysmetabolism, and inflammation in neurological diseases

Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260

Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

Tobinick, E. L., & Gross, H. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-2 · Cited by 250

Inflammatory markers and the risk of dementia and Alzheimer's disease: a meta-analysis

Darweesh, S. K. L., Wolters, F. J., Ikram, M. A., de Wolf, F., Bos, D., & Hofman, A. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.014 · Cited by 244

Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife

Singh-Manoux, A., Dugravot, A., Brunner, E., Kumari, M., Shipley, M., Elbaz, A., & Kivimaki, M. (2014) · Neurology · doi:10.1212/wnl.0000000000000665 · Cited by 237

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Ardura-Fabregat, A., Boddeke, E., Boza‐Serrano, A., Brioschi, S., Castro‐Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 241

Inflammation and nutritional science for programs/policies and interpretation of research evidence (INSPIRE)

Raiten, D. J., Ashour, F. A. S., Ross, A. C., Meydani, S. N., Dawson, H. D., Stephensen, C. B., Brabin, B. J., Suchdev, P. S., & van Ommen, B. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.194571 · Cited by 234

Is Alzheimer’s disease a systemic disease?

Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219

Interleukin-1β and the Autoinflammatory Diseases

Dinarello, C. A. (2009) · New England Journal of Medicine · doi:10.1056/nejme0811014 · Cited by 228

Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease

Galasko, D. R., & Montine, T. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.89 · Cited by 231

Adiposity, Type 2 Diabetes, and Alzheimer's Disease

Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 221

Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders

Filippo, M. D., Sarchielli, P., Picconi, B., & Calabresi, P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.005 · Cited by 218

Inflammation context in Alzheimer’s disease, a relationship intricate to define

Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target

Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204

Association of C-Reactive Protein With Cognitive Impairment

Noble, J. M., Manly, J. J., Schupf, N., Tang, M. X., Mayeux, R. P., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.308 · Cited by 209

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

Honjo, K., van Reekum, R., & Verhoeff, N. P. L. G. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.12.001 · Cited by 208

The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease

Sundman, M., Chen, N., Subbian, V., & Chou, Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.009 · Cited by 204

Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease

van Himbergen, T. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.670 · Cited by 202

The Role of Inflammation in the Pathogenesis of Delirium and Dementia in Older Adults: A Review

Simone, M. J., & Tan, Z. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00173.x · Cited by 204

Anesthetic Sevoflurane Causes Neurotoxicity Differently in Neonatal Naïve and Alzheimer Disease Transgenic Mice

Lu, Y., Wu, X., Dong, Y., Xu, Z., Zhang, Y., & Xie, Z. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d94de1 · Cited by 195

Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease

Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Grigoriadis, N., Deretzi, G., Tzilves, D., Katsinelos, P., Tsolaki, M., Chatzopoulos, D., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5011-z · Cited by 190

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk

Samieri, C., Féart, C., Letenneur, L., Dartigues, J.-F., Pérès, K., Auriacombe, S., Peuchant, E., Delcourt, C., & Barberger-Gateau, P. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.714 · Cited by 184

Blood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible

Thambisetty, M., & Lovestone, S. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.84 · Cited by 182

Cognitive dysfunction with aging and the role of inflammation

Simen, A. A., Bordner, K. A., Martin, M. P., Moy, L. A., & Barry, L. C. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311399145 · Cited by 186

GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo

Hu, N., Klyubin, I. V., Anwyl, R., & Rowan, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908083106 · Cited by 176

Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies

Cavalli, G., & Dinarello, C. A. (2015) · Rheumatology · doi:10.1093/rheumatology/kev269 · Cited by 178

Cardiovascular Disease and Cognitive Decline in Postmenopausal Women: Results From the Women's Health Initiative Memory Study

Haring, B., Leng, X., Robinson, J. G., Johnson, K., Jackson, R. D., Beyth, R. J., Wactawski‐Wende, J., von Ballmoos, M. C. W., Goveas, J. S., Kuller, L. H., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000369 · Cited by 162

Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction

Rowan, M. J., Klyubin, I. V., Wang, Q., Hu, N., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 154

Chapter 5 Biomarkers Related To Aging In Human Populations

Crimmins, E. M., Vasunilashorn, S. M., Kim, J. K., & Alley, D. E. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)00405-8 · Cited by 159

Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results

Baudron, C. R., Krolak‐Salmon, P., Quadrio, I., Mégraud, F., & Salles, N. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.021 · Cited by 152

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

Janelsins, M. C., Mustian, K. M., Palesh, O. G., Mohile, S. G., Peppone, L. J., Sprod, L. K., Heckler, C. E., Roscoe, J. A., Katz, A. W., Williams, J. P., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1158-0 · Cited by 150

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease

Desikan, R. S., Schork, A. J., Wang, Y., Thompson, W. K., Dehghan, A., Ridker, P. M., Chasman, D. I., McEvoy, L. K., Holland, D., Chen, C.-H., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015489 · Cited by 154

Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study

Walker, K. A., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Windham, B. G., Jack, C. R., & Gottesman, R. F. (2017) · Neurology · doi:10.1212/wnl.0000000000004688 · Cited by 150

Is there an association between peripheral immune markers and structural/functional neuroimaging findings?

Frodl, T., & Amico, F. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.013 · Cited by 150

Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?

Mandelblatt, J. S., Hurria, A., McDonald, B. C., Saykin, A. J., Stern, R. A., VanMeter, J. W., McGuckin, M., Traina, T., Denduluri, N., Turner, R. S., et al. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.006 · Cited by 155

Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by Lipopolysaccharide

Maitra, U., Deng, H., Glaros, T., Baker, B., Capelluto, D. G. S., Li, Z., & Li, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200857 · Cited by 151

Cytokines and Brain Injury: Invited Review

Kadhim, H. J., Duchateau, J., & Sébire, G. (2008) · Journal of Intensive Care Medicine · doi:10.1177/0885066608318458 · Cited by 142

Current and future uses of neuroimaging for cognitively impaired patients

Small, G. W., Bookheimer, S. Y., Thompson, P. M., Cole, G. M., Huang, S.-C., Kepe, V., & Barrio, J. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70019-x · Cited by 145

Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging

Chen, W., Song, X., Zhang, Y., & Initiative, F. T. A. D. N. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2541 · Cited by 130

Cytokines and Myelination in the Central Nervous System

Schmitz, T., & Chew, L. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.140 · Cited by 141

Oxidative Stress-Mediated Aging during the Fetal and Perinatal Periods

Marseglia, L. M., D’Angelo, G., Manti, S., Arrigo, T., Barberi, I., Reiter, R. J., & Gitto, E. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/358375 · Cited by 141

Inflammatory aspects of Alzheimer’s disease

Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 152

Progranulin Mutations as Risk Factors for Alzheimer Disease

Perry, D. C., Lehmann, M., Yokoyama, J. S., Karydas, A., Lee, J. J., Coppola, G., Grinberg, L. T., Geschwind, D. H., Seeley, W. W., Miller, B. L., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.393 · Cited by 133

Association of C‐reactive protein with mild cognitive impairment

Roberts, R. O., Geda, Y. E., Knopman, D. S., Boeve, B. F., Christianson, T. J. H., Pankratz, V. S., Kullo, I. J., Tangalos, E. G., Ivnik, R. J., & Petersen, R. C. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.025 · Cited by 136

PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION: Cytokines, Resiliency Proteins and Major Depression

Martinez, J. M., Garakani, A., Yehuda, R., & Gorman, J. M. (2012) · Depression and Anxiety · doi:10.1002/da.20876 · Cited by 131

Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?

Kawamura, T., Umemura, T., & Hotta, N. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00234.x · Cited by 131

A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats

Rai, S., Kamat, P. K., Nath, C., & Shukla, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.008 · Cited by 129

Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease

Watts, A. S., Gatz, M., & Crimmins, E. M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3610 · Cited by 129

PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

Zolezzi, J. M., Santos, M. J., Candia, S. B., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12320 · Cited by 123

Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer’s Disease: a Review of Current Evidence

Honarvar, N. M., Saedisomeolia, A., Abdolahi, M., Shayeganrad, A., Sangsari, G. T., Rad, B. H., & Muench, G. W. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0857-x · Cited by 123

Strength Training Decreases Inflammation and Increases Cognition and Physical Fitness in Older Women with Cognitive Impairment

Chupel, M. U., Direito, F., Furtado, G. E., Minuzzi, L. G., Pedrosa, F. M., Colado, J. C., Ferreira, J. P., Filaire, E., & Teixeira, A. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00377 · Cited by 127

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis

Keizman, D., Rogowski, O., Berliner, S. A., Ish‐Shalom, M., Maimon, N., Nefussy, B., Artamonov, I., & Drory, V. E. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01112.x · Cited by 118

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Tobinick, E. (2009) · CNS Drugs · doi:10.2165/11310810-000000000-00000 · Cited by 117

Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo

Chakrabarty, P., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-16 · Cited by 117

Fisetin Enhances Behavioral Performances and Attenuates Reactive Gliosis and Inflammation During Aluminum Chloride-Induced Neurotoxicity

Dharmalingam, P., Gopinath, K., & Sudhandiran, G. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8210-1 · Cited by 122

Interleukin-18 produced by peripheral blood cells is increased in Alzheimer’s disease and correlates with cognitive impairment

Bossù, P., Ciaramella, A., Salani, F., Bizzoni, F., Varsi, E., Di Iulio, F., Giubilei, F., Gianni, W., Trequattrini, A., Moro, M. L., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.10.001 · Cited by 116

Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease

Fagan, A. M., & Perrin, R. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.42 · Cited by 118

Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid -Protein Oligomers

Xu, H., Gelyana, E., Rajsombath, M., Yang, T., Li, S., & Selkoe, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1023-16.2016 · Cited by 109

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease

Tobinick, E. L., & Gross, H. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-27 · Cited by 111

Precision pharmacology for Alzheimer’s disease

Hampel, H. J., Vergallo, A., Aguilar, L. F., Benda, N., Broich, K., Cuello, A. C., Cummings, J. L., Dubois, B., Federoff, H. J., Fiandaca, M. S., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.014 · Cited by 114

Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer’s Disease

Paouri, E., & Georgopoulos, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321154618 · Cited by 109

Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease

Eikelenboom, P., Hoozemans, J. J. M., Veerhuis, R., van Exel, E. R., Rozemüller, A. J. M., & van Gool, W. A. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt118 · Cited by 110

Longitudinal Inflammation, Cognitive Decline, and Alzheimer’s Disease: A Mini-Review

Bettcher, B. M., & Kramer, J. H. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.147 · Cited by 107

Long‐Term Systemic Inflammation and Cognitive Impairment in a Population‐Based Cohort

Wichmann, M. A., Cruickshanks, K. J., Carlsson, C. M., Chappell, R. J., Fischer, M., Klein, R., Klein, R., Tsai, M. Y., & Schubert, C. R. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12994 · Cited by 105

A lzheimer's disease and chronic periodontitis: Is there an association?

Gaur, S., & Agnihotri, R. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12425 · Cited by 116

Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Diniz, B. S., Teixeira, A. L., Ojopi, E. P. B., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100921 · Cited by 99

Osteoarthritis Increases the Risk of Dementia: A Nationwide Cohort Study in Taiwan

Huang, S., Wang, W.-T., Chou, L.-C., Liao, C., Liou, T., & Lin, H. (2015) · Scientific Reports · doi:10.1038/srep10145 · Cited by 106

Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population

Gu, Y., Vorburger, R. S., Scarmeas, N., Luchsinger, J. A., Manly, J. J., Schupf, N., Mayeux, R. P., & Brickman, A. M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.022 · Cited by 105

Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: A pro-inflammatory pathway in rats

Gong, Q., Wang, Q., Pan, L., Liu, X., Huang, H., & Zhu, Y. Z. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.006 · Cited by 99

MIRNAS in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity

Lafourcade, C., Ramírez, J. P., Luarte, A., Fernández, A., & Wyneken, Ú. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s39916 · Cited by 105

DNA Methylation and Protein Markers of Chronic Inflammation and Their Associations With Brain and Cognitive Aging

Conole, E. L. S., Stevenson, A. J., Maniega, S. M., Harris, S. E., Maniega, S. M., Hernández, M. V., Harris, M. A., Bastin, M. E., Wardlaw, J. M., Deary, I. J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012997 · Cited by 102

Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood–brain barrier: Protection by the antioxidant N-acetylcysteine

Erickson, M. A., Hansen, K. M., & Banks, W. A. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.07.003 · Cited by 102

Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons

He, P., Liu, Q., Wu, J., & Shen, Y. (2011) · The FASEB Journal · doi:10.1096/fj.11-192716 · Cited by 96

Inflammatory Cytokines and Comorbidity Development in Breast Cancer Survivors Versus Noncancer Controls: Evidence for Accelerated Aging?

Alfano, C. M., Peng, J., Andridge, R., Lindgren, M. E., Povoski, S. P., Lipari, A. M., Agnese, D. M., Farrar, W. B., Yee, L. D., Carson, W. E., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.1883 · Cited by 97

P1–209: Relations of serum inflammatory markers and monocyte production of cytokines to the risk for Alzheimer's disease: The Framingham study

Tan, Z. S., Seshadri, S. S., Beiser, A., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Vasan, R. S., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.586

P1‐210: Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment

Silvestri, A., Latini, A., Catucci, A. E., Caminiti, G., Pierangeli, D., Rosano, G. M. C., Fini, M., & Pagano, A. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.799

Levels of IL-6 in peripheral blood and cerebrospinal fluid of Alzheimer's disease: a meta-analysis

Xinyu Li1, W. W. (2023) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2023.050210

Detection of interleukin-1、interleukin-6 and tumor necrosis factor in serum in patients with Alzheimer disease

Zhongl, H. (2010) · Modern Practical Medicine · Cited by 1

APOE epsilon-4 allele and cytokine production in Alzheimer's disease

Olgiati, P., Politis, A., Malitas, P., Albani, D., Dusi, S., Polito, L., De Mauro, S., Zisaki, A., Piperi, C., Stamouli, E., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2344 · Cited by 35